Todd correll

Todd Correll is a PharmD who completed his Pharmacy training at Philadelphia College of Pharmacy followed by a Pharmacy Practice Residency at Shands at University of Florida. He proceeded to complete an Infectious Diseases/HIV Specialized Pharmacy Residency at the University of North Carolina. He has been at Merck for 4 years and is the Product Development Team Lead for Doravirine/Islatravir program which is being evaluating for the treatment of HIV-1..